Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 18th October 2011
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
PCV2 Experts to be at PVS Conference
Two PCV2 expert will feature prominently at the Pig Veterinary Society's next meeting.
 
The Pig Veterinary Society's autumn meeting, taking place in mid-November, will feature two leading experts in PCV2.

Dr Kenneth McCullough, head of research at Switzerland's Institute of Virology and Immunoprophylaxis, will be talking about  the impact of PCV2 on the immune system, explaining how it impairs the immune response of pigs and why early protection is essential.

Thais Vila, a technical director for EMEA for swine products, will address PCV2 vaccination. She aims to explain how it can be used to protect piglets, gilts and sows and how it can provide full control and flexibility to prevents losses from service to slaughter.

Since its identification in the 1990s, PCV2 has been shown to have significant health and economic effects on pigs around the world.

Brian Rice, a veterinary advisor at Merial Animal Health, commented on the upcoming sessions, saying: "They will undoubtedly help delegates to improve their understanding of PCV2 and its effect on the immune system, as well as the treatment open to them."

The PVS autumn meeting will take place on 16-17th November, at the East Midlands Hilton Hotel. For more information, click here.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.